Addiction: A Paradigm Shift from Problem to Patient through Policy: A Health Policy and Bioethics Consortium
Online Viewing
In light of the rapidly developing COVID-19 outbreaks, Harvard University has restricted on-campus events. As a result, we will not be allowing in-person attendance at this event. Instead, the full panel discussion will be available for viewing online. To ensure that you will receive access to the livestream and be kept up to date on any changes to the event, register now. We will send out a link to the livestream of the event to all registrants the day before the event.
Hosting events, even ones that are largely virtual, is a constantly moving target these days and we appreciate your patience and flexibility as we fine tune our approach. In the meantime, we hope you all stay well.
Description
Addiction is one of numerous public health crises facing the US today. Treatment for severe substance use disorders (i.e., addiction) has evolved over time as science has advanced to better understand addiction as a chronic disease, acceptance of evidence-based practice guidelines, and availability of safe and effective treatments. Patients, however, still face barriers to engaging treatment for a variety of reasons (e.g., cost, stigma, limited resources), some of which will be explored in greater depth in this session. Thus, efforts to craft better policies that improve access to and affordable care for substance use disorder treatments are important.
This event is free and can be viewed online by the public, but registration is required. Register now!
Panelists
-
Joshua Sharfstein, Vice Dean for Public Health Practice and Community Engagement, Johns Hopkins Bloomberg School of Public Health
-
Brandon del Pozo, ex-Chief of Police, Burlington, Vermont
-
Rachel Barenie, Postdoctoral Fellow, Program On Regulation, Therapeutics, and Law (PORTAL)
The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations.
They are organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.
Tags
addiction health law policy health policy and bioethics consortia